Free shipping on all orders over $ 500
Inhibitors
| Cat.No. | Name | Information |
|---|---|---|
| M10432 | Difelikefalin (CR-845; FE-202845) TFA | Difelikefalin (CR-845; FE-202845) TFA is a peripherally restricted and selective agonist of kappa opioid receptor (KOR). |
| M10240 | CTOP TFA | CTOP TFA is a peptide that acts as a potent and selective μ opioid receptor antagonist, with Ki values of 0.96 and >10,000 nM for μ and δ receptors, respectively. |
| M10229 | Porcine dynorphin A (1-13) | Porcine dynorphin A (1-13) is a potent, endogenous κ opioid receptor agonist. |
| M9784 | Naloxegol oxalate | Naloxegol oxalate (NKTR-118 oxalate; AZ-13337019 oxalate) is a peripherally-selective opioid antagonist for the treatment of opioid-induced constipation. |
| M9615 | DAMGO | DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents, Kd value is 3.46 nM for native μ-OPR. |
| M9514 | JDTic | JDTic is a kappa opioid receptor (KOR) antagonist that prevents stress-induced reinstatement of cocaine-maintained responding and has antidepressant-like effects. |
| M9268 | Met-Enkephalin | Met-Enkephalin (H-Tyr-Gly-Gly-Phe-Met-OH) inhibits tumor growth via binding to the opioid receptor. |
| M6036 | Trimebutine maleate | Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects. |
| M6035 | Trimebutine | Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain. |
| M5589 | Docusate Sodium | Docusate Sodium is a laxative used to treat constipation, for constipation due to the use of opiates it maybe used with a stimulant laxative, can be taken by mouth or rectally. |
| M5403 | Alvimopan dihydrate | Alvimopan dihydrate(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
| M5289 | PZM21 | PZM21 is a potent and selective μ-opioid-receptor (μOR) agonist with an EC50 of 1.8 nM. |
| M5067 | Eluxadoline | Eluxadoline is an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist. |
| M5065 | Cebranopadol | Cebranopadol is a novel first in class compounds with potent agonist activity on ORL-1 (opioid receptor like -1) and the well established mu opioid receptor. |
| M4808 | TRV130 hydrochloride | TRV130 hydrochloride (Oliceridine) is a novel μ-opioid receptor (MOR) G protein-biased ligand. |
| M3582 | Racecadotril | Racecadotril is a peripherally acting enkephalinase inhibitor with an IC50 of 4.5 μM |
| M2991 | SA 4503 | SA 4503 is a novel and selective opioid sigma1 receptor agonist with IC50 of 17.4 nM. |
| M2876 | Naloxone hydrochloride | Naloxone hydrochloride is an opioid inverse agonist compound used to counter the effects of opiate overdose. |
| M2214 | JTC-801 | JTC-801 is a novel opioid receptor-like1 (ORL1) receptor antagonist with IC50 of 94 nM. |
| M2145 | Loperamide hydrochloride | Loperamide hydrochloride is a high affinity μ-opioid receptor agonist with peripheral selectivity with Ki values of 2, 48 and 1156 nM for μ-, δ- and κ-opioid receptors respectively. |
| M1953 | ADL5859 Hydrochloride | ADL5859 is a potent, selective and orally bioavailable δ-opioid receptor agonist (Ki = 0.84 nM, EC50 = 20 nM). |
| M1577 | Naltrexone Hydrochloride | Naltrexone hydrochlorideis an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.
